The novel IDO-1 inhibitor 3-047 combined with icaritin ameliorates neuroinflammation and diabetes-associated cognitive dysfunction with suppression of TLR4/MyD88/NF-κB signaling
3-047 combined with ICT reduces neuronal apoptosis and neuroinflammation and improves cognitive dysfunction in diabetic mice, and these effects are potentially associated with downregulation of the TLR4/MyD88/NF-κB pathway.
Authors
- D.G. Liu (ORCID: https://orcid.org/0009-0002-2204-2386)
- Yan Xu (ORCID: https://orcid.org/0009-0001-3964-4343)
- Ru Yao
- Wenxue Zhao
- Yuting Wang
- Xia Zhuang
- Tingmei Mo
- Guimin Zhang
- Wenjie Ji
- Baohua Wang
- Jingchun Yao
Institutions
- Qingdao University (CN)
- Shandong University of Traditional Chinese Medicine (CN)
- Guangdong Pharmaceutical University (CN)
- Changchun University of Chinese Medicine (CN)
- Pharmaceutical Formulations (United States) (US)
- Luye Pharma (China) (CN)
- The Affiliated Hospital to Changchun University of Chinese Medicine (CN)
- Ocean University of China (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-26
- DOI
- https://doi.org/10.3389/fimmu.2026.1704307
- Primary Topic
- Medicinal Plant Pharmacodynamics Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00